Which hedge funds own SRRK? SCHOLAR ROCK HLDG CORP, Q2 2026 13F holders
52 tracked hedge funds disclosed a position in SRRK (SCHOLAR ROCK HLDG CORP) in their Q2 2026 13F filings, worth $1.0bn in total. The largest holder by portfolio weight is Redmile Group, LLC at 15.9% of its book. 15 opened a new position this quarter: Beaconlight Capital, LLC, Logos Global Management LP, Senator Investment Group LP, Ghisallo Capital Management LLC. 9 exited: Silverarc Capital Management, LLC, Vestal Point Capital, LP, Paradigm Biocapital Advisors LP.
- 52
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 15
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 9
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $68.0m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $166m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $1.0bn
- Combined value Sum of the holders' reported positions in the security.
- 4.2%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Silverarc Capital Management, LLC | 2.0% | $16.7m |
| Vestal Point Capital, LP | 1.8% | $65.1m |
| Paradigm Biocapital Advisors LP | 1.2% | $60.3m |
| ADAR1 Capital Management, LLC | 1.2% | $20.0m |
| ExodusPoint Capital Management, LP | 0.03% | $3.3m |
| RWC Asset Management LLP | 0.01% | $221k |
| Brevan Howard Capital Management LP | 0.0% | $380k |
| Farallon Capital Management, L.L.C. | 0.0% | $344k |
| Quantbot Technologies LP | 0.0% | $39.0k |
Ownership over time
Who discovered SRRK first? Beta
The run: Q3 2024 → Q2 2026, +587%
| Stempoint Capital LP high conviction | Q4 2024 | – | +3.4 pts |
| Exome Asset Management LLC | Q4 2024 | 0.8% | +2.9 pts |
| Integral Health Asset Management, LLC | Q4 2024 | 0.3% | +0.8 pts |
| Rock Springs Capital Management LP | Q4 2024 | – | +0.7 pts |
| Orbimed Advisors LLC | Q4 2023 | 0.1% | +0.3 pts |
| Commodore Capital LP | Q4 2024 | – | −0.4 pts |
| Octagon Capital Advisors LP | Q4 2024 | – | −0.9 pts |
| Fairmount Funds Management LLC high conviction | Q4 2024 | – | −1.0 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.